Psychedelics and Cannabis: A Look at the Converging Investment Landscape
Sheeba explores the growing convergence between the cannabis and psychedelics sectors. Both industries face similar regulatory hurdles and market development challenges. Investment opportunities…
Emerging Cannabis Product Trends for 2026
Sheeba highlights innovative cannabis product trends for 2026, focusing on advanced edibles, targeted vapes, and wellness-oriented topicals. The market is seeing a surge in microdosing options and…
Federal Cannabis Legalization Outlook: What to Expect in the US
Sheeba analyzes the federal cannabis legalization landscape, noting slow but steady progress. Descheduling efforts and the SAFER Banking Act are key legislative battlegrounds. While full legalization…
Global Cannabis Investment Opportunities Beyond North America
Sheeba highlights global cannabis investment trends, focusing on Europe”s emerging medical and recreational markets, Latin America”s cultivation potential, and Oceania”s regulatory advancements.…
Schedule III Relief: The Big Players Win, Smaller MSOs Squeezed
Schedule III relief disproportionately helps big players like GTI & Trulieve; smaller MSOs still fighting for margin.
Cannabis Retail Saturation: The Race to the Bottom Has Begun
Mature markets face brutal price compression; only scale and efficiency survive.
Cannabis Tax Reform 2026: The Game-Changer Nobody’s Talking About
280E relief is coming. Companies are leaner. Margins are about to expand big.
ACH Revolution: 42% of Cannabis Transactions Going Digital in 2026
Banking access is the unglamorous catalyst that changes everything. Cash is being replaced by digital rails.
License Contraction = Consolidation Opportunity: Why Scale Wins in 2026
13% license contraction = consolidation opportunity. Scale wins. Big players get bigger.
Trulieve Q4 2025: Record Cash Flow Signals Market Strength
Trulieve Cannabis reports strong Q4 earnings with record cash flow generation, proving cannabis retail can thrive at scale.